M Lein, B Brux, K Jung, W Henke, F Koenig, C Stephan, D Schnorr, S A Loening
{"title":"根治性耻骨后前列腺切除术后血清游离和总前列腺特异性抗原的消除。","authors":"M Lein, B Brux, K Jung, W Henke, F Koenig, C Stephan, D Schnorr, S A Loening","doi":"10.1515/cclm.1997.35.8.591","DOIUrl":null,"url":null,"abstract":"<p><p>Elimination kinetics of serum total and free prostate-specific antigen were studied for a ten days course after radical retropubic prostatectomy on 11 patients suffering from organ confined prostate cancer. Samples were taken before operation, immediately after finishing the operation and 1, 2, 3, 4, 5, 6 h after prostatectomy and then once a day for the following ten days. The measurements were performed with AxSym assays from Abbott Laboratories. The elimination of both total and free prostate-specific antigen followed a biphasic kinetics. In the fast phase, the average of the individual elimination half-lives of total and free prostate-specific antigen amounted to 6.3 h (SD = 6.1 h; range: 0.55 to 37.1 h) and 0.57 h (SD = 0.18 h; range: 0.22 to 0.89 h), respectively. In the slow phase, total prostate-specific antigen disappeared with an average half-life of 85.6 h (SD = 11 h; range: 47.2 to 261.7 h) and free prostate-specific antigen with an average half-life of 14.4 h (SD = 10.4 h; range: 2.4 to 30.3 h). These results might be significant for the use of free and total prostate-specific antigen and its ratio as a diagnostic and prognostic tool.</p>","PeriodicalId":77119,"journal":{"name":"European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies","volume":"35 8","pages":"591-5"},"PeriodicalIF":0.0000,"publicationDate":"1997-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1515/cclm.1997.35.8.591","citationCount":"23","resultStr":"{\"title\":\"Elimination of serum free and total prostate-specific antigen after radical retropubic prostatectomy.\",\"authors\":\"M Lein, B Brux, K Jung, W Henke, F Koenig, C Stephan, D Schnorr, S A Loening\",\"doi\":\"10.1515/cclm.1997.35.8.591\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Elimination kinetics of serum total and free prostate-specific antigen were studied for a ten days course after radical retropubic prostatectomy on 11 patients suffering from organ confined prostate cancer. Samples were taken before operation, immediately after finishing the operation and 1, 2, 3, 4, 5, 6 h after prostatectomy and then once a day for the following ten days. The measurements were performed with AxSym assays from Abbott Laboratories. The elimination of both total and free prostate-specific antigen followed a biphasic kinetics. In the fast phase, the average of the individual elimination half-lives of total and free prostate-specific antigen amounted to 6.3 h (SD = 6.1 h; range: 0.55 to 37.1 h) and 0.57 h (SD = 0.18 h; range: 0.22 to 0.89 h), respectively. In the slow phase, total prostate-specific antigen disappeared with an average half-life of 85.6 h (SD = 11 h; range: 47.2 to 261.7 h) and free prostate-specific antigen with an average half-life of 14.4 h (SD = 10.4 h; range: 2.4 to 30.3 h). These results might be significant for the use of free and total prostate-specific antigen and its ratio as a diagnostic and prognostic tool.</p>\",\"PeriodicalId\":77119,\"journal\":{\"name\":\"European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies\",\"volume\":\"35 8\",\"pages\":\"591-5\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1997-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1515/cclm.1997.35.8.591\",\"citationCount\":\"23\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1515/cclm.1997.35.8.591\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1515/cclm.1997.35.8.591","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 23
摘要
对11例器官局限性前列腺癌患者行根治性耻骨后前列腺切除术后10天内血清总抗原和游离前列腺特异性抗原的消除动力学进行了研究。术前、术后即刻及前列腺切除术后1、2、3、4、5、6 h取标本,此后10天每天1次。测量采用雅培公司的AxSym测定法。总和游离前列腺特异性抗原的消除遵循双相动力学。快速期总抗原和游离前列腺特异性抗原的个体消除半衰期平均为6.3 h (SD = 6.1 h);范围:0.55 ~ 37.1 h)和0.57 h (SD = 0.18 h;范围:0.22至0.89小时)。在慢期,前列腺特异性抗原消失,平均半衰期为85.6 h (SD = 11 h;范围:47.2 ~ 261.7 h)和游离前列腺特异性抗原,平均半衰期为14.4 h (SD = 10.4 h;范围:2.4 ~ 30.3 h)。这些结果可能对使用游离和总前列腺特异性抗原及其比值作为诊断和预后工具具有重要意义。
Elimination of serum free and total prostate-specific antigen after radical retropubic prostatectomy.
Elimination kinetics of serum total and free prostate-specific antigen were studied for a ten days course after radical retropubic prostatectomy on 11 patients suffering from organ confined prostate cancer. Samples were taken before operation, immediately after finishing the operation and 1, 2, 3, 4, 5, 6 h after prostatectomy and then once a day for the following ten days. The measurements were performed with AxSym assays from Abbott Laboratories. The elimination of both total and free prostate-specific antigen followed a biphasic kinetics. In the fast phase, the average of the individual elimination half-lives of total and free prostate-specific antigen amounted to 6.3 h (SD = 6.1 h; range: 0.55 to 37.1 h) and 0.57 h (SD = 0.18 h; range: 0.22 to 0.89 h), respectively. In the slow phase, total prostate-specific antigen disappeared with an average half-life of 85.6 h (SD = 11 h; range: 47.2 to 261.7 h) and free prostate-specific antigen with an average half-life of 14.4 h (SD = 10.4 h; range: 2.4 to 30.3 h). These results might be significant for the use of free and total prostate-specific antigen and its ratio as a diagnostic and prognostic tool.